ArticleHuman gene therapy2020

Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors.

Joshua D Bernstock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.